Counting mitotic figures, a crucial criterion for assessment of grade in numerous cancers, is inherently time-consuming and suffers from significant inter-observer variability.
Our AI-driven algorithm for precise mitosis quantification and profiling offers enhanced pathology workflows by increasing the reliability, speed and depth of analysis.
This tool is currently for research use only and is currently going through CE-IVDR regulation.
Tools for hospitals and pharma
Clinical
Pharma
AI-powered counting and analysis of mitotic figures to improve pathology workflow efficiency during grading of multiple cancer types.
AI-enabled mitosis profiling over the entire tissue sample to enable large-scale assessment of proliferation and patient outcome.
"Despite its importance, manual mitosis counting can be tedious and suffers from significant variation between pathologists. As well as improving the reliability of the current standard of care, MitPro® can precisely recognise mitotic figures across the entire tumour, enabling large-scale assessment of novel biomarkers."
Prof David Snead
Chief Medical Officer, Histofy
Reduced time required for analysis
Improved reliability in mitosis counting
Profiling across entire slide
Next-generation mitosis profiling
Seamless integration with existing workflows
Our vendor agnostic technology directly integrates with pathology image management systems to facilitate trouble-free adoption of AI
MitPro® is a next-generation AI solution capable of detecting, precisely quantifying and profiling mitosis across various cancer types within specific regions of interest (RoIs) and entire whole-slide images (WSIs). MitPro® identifies and displays mitotic figures within the requested region and displays the results in an interactive gallery. Additionally, MitPro® can be automatically triggered at the WSI level when a slide is uploaded, seamlessly integrating with existing workflows. When processing the entire WSI, MitPro® also locates the site of maximum mitotic activity as a mitotic hotspot.
Accelerating the adoption of of AI-powered mitosis analysis
Histofy, a company specialising in developing transparent AI for pathology, today announces a project to develop an AI-powered system that provides precise quantification …